Cooper Lab
The Cooper Lab conducts clinical and translational studies on patients with pituitary disease, focusing on optimizing care for pituitary patients, aggressive pituitary adenomas and metabolic complications from craniopharyngiomas.
Personal Statement
I am a physician scientist at the Pituitary Center and Division of Endocrinology, Diabetes and Metabolism researching pituitary tumorigenesis, therapies for aggressive pituitary tumors and metabolic complications of sellar/parasellar tumors. I am also the director of the Clinical and Translational Research Center, facilitating implementation of clinical trials across the institution.
Odelia Cooper, MD
Breakthrough Research
- Characterized metabolic complications in patients with adult-onset craniopharyngioma
- Optimized perioperative protocol for pituitary surgery
- Defined the role of the EGFR pathway and therapeutics in aggressive prolactinomas
Funded Research
Learn about the funding sources for our leading research programs.
Publications
Learn more about the recent research publications from the Cooper Lab.
Laboratory Team
Learn more about the scientists, faculty members, investigators and other healthcare professionals of the Cooper Laboratory, whose dedicated efforts lead to groundbreaking discoveries.
Job Opportunities
We are actively recruiting students and postdocs to be our colleagues and expand lab knowledge and expertise to make important breakthroughs.
Collaborations
The Cooper Lab collaborates with a wide range of investigators within Cedars-Sinai and in institutions around the world.
- Johns Hopkins University School of Medicine
- University of California, San Francisco
- University of Southern California
- University of California, Los Angeles